figshare
Browse
gnpl_a_2174538_sm7827.pdf (610.25 kB)

The interaction of anti-inflammatory and anti-tumor components in the traditional Chinese medicine Solanum lyratum Thunb

Download (610.25 kB)
journal contribution
posted on 2023-02-16, 13:20 authored by Dian Zou, Xiaohua Li, Xinxin Zhou, Biaobiao Luo, Mohammad Omar Faruque, Sheng Hu, Jian Chen, Xuebo Hu

Solanum lyratum Thunb is a traditional Chinese medicinal with a significant clinical outcome for tumor treatment; however, chemicals or fractions separated from the herb did not exhibit strong and comparable efficacy. To investigate the potential synergy or antagonism among chemicals in the extract, we obtained the compounds solavetivone (SO), tigogenin (TI) and friedelin (FR) from the herb. The anti-tumor effects of these three monomer compounds alone or in combination with the anti-inflammatory compound DRG were also tested in this study. SO, FR and TI used alone did not inhibit the proliferation of A549 and HepG2 cells, but the combination of the three achieved 40% inhibition. In vitro anti-inflammatory analysis showed that DRG had a stronger anti-inflammatory effect than TS at the same concentration, and the combination of DRG with SO, FR or TI inhibited the anti-tumor effect of DRG. This is the first study that documented the synergistic and antagonistic interactions between different compounds in a single herb.

Funding

This research was supported by Shengnongjia Academy of Forestry, Hubei, China (No. SAF202102), Hubei Technology Innovation Center for Agricultural Sciences – ‘2020 key technology research and demonstration project of safe and efficient production of genuine medicinal materials’ (No. 2020-620-000-002-04) to XH. The project was supported by Health Commision of Hubei Province (ZY2019M032) to JC. The research was also supported by National Science & Technology Fundamental Resources Investigation Program of China (No. 2018FY100704) to XL.

History